At FH23, Mathis Wilke, Managing Director and Head of the German-speaking region for Stout, provided a comprehensive overview of the healthtech landscape and current trends shaping the digital health space.

He also discussed macroeconomic factors influencing the market, deal activity, as well as current valuation levels and their evolution over the past 24 months.

Download your copy of "Venture Capital Trends in Digital Health 2023“

Executive Summary

The "Venture Capital Trends in Digital Health 2023" report presents an in-depth analysis of the HealthTech sector, highlighting significant trends and shifts in the venture capital landscape as well as current valuation levels including a detailed collection of valuation data and benchmarks. The sector, essential to tomorrow's society, is experiencing a notable transformation due to various macroeconomic factors, including uncertainties and investor worries in the current adverse environment. Notably, there has been a strong reduction in mergers and acquisitions (M&A) and investment activities, particularly for late-stage and mega-rounds, with many companies postponing fundraising efforts to 2024. This delay suggests a fierce competition in the coming year. Meanwhile, public valuation levels have stabilized, though they remain below the highs of 2021. 

Investor priorities are undergoing a fundamental shift, now favouring proven profitability over potential growth milestones. This change is affecting different stages of investment differently, with early-stage investments being modestly affected, while late-stage rounds and exits face challenges. The adoption of Environmental, Social, and Governance (ESG) guidelines is becoming a new standard, with a majority of private equity firms transitioning from policy formulation to ESG implementation, indicating a growing consensus that a strong ESG focus can drive superior financial performance.

The report also delves into the role of artificial intelligence (AI) in healthcare, highlighting its transformative potential in disease detection, drug discovery, and tool integration. However, the expansion of AI is not without challenges, as it raises concerns about potential risks, regulatory complexities, and introduces new vulnerabilities that necessitate significant security investments.

The HealthTech market is characterized by the dominance of specialists and renowned general technology funds with dedicated HealthTech professionals. The rankings of these key players vary based on subsector, geography, and stage. A notable trend in the sector is the increasing emphasis on vertical integration strategies by major players, aiming to expand their reach across various segments like providers, pharmacies, insurance, benefit management, data services, diagnostics, and digital therapeutics.

Lastly, the report addresses the crucial role of digital health reimbursement, especially in the European markets like Germany, where out-of-pocket healthcare spending is uncommon. The report underscores that comprehensive reimbursement frameworks for digital health are pivotal for achieving large-scale adoption of digital health services. This focus on reimbursement strategies highlights the evolving dynamics of the HealthTech sector, where financial and regulatory considerations are as crucial as technological advancements.